Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × enasidenib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Leukemia, Myelomonocytic, Chronic 3 Myelodysplastic Syndromes 2 Leukemia 2 Sinonasal undifferentiated carcinoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Esthesioneuroblastoma, Olfactory 1 Clonal Cytopenia of Undetermined Significance 1 Chondrosarcoma 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡